Julphar
Basel Ziyadeh has extensive work experience in the pharmaceutical industry. Basel is currently serving as the Chief Executive Officer of Julphar since February 2023. Prior to this, they worked as an Independent Consultant from August 2021 to December 2022. Before that, Basel held the position of Chief Executive Officer at Tabuk Pharmaceuticals Manufacturing Company from November 2019 to July 2021. Basel also served in various roles at Hikma Pharmaceuticals, including Vice President for the Middle East & North Africa, Vice President for LEVANT, General Manager for KSA & GCC, Director of Sales and Marketing for KSA & GCC, Director of Marketing for the Middle East & North Africa, and Marketing Manager for the Middle East, North Africa, and Injectables. Basel started their career as a Medical Representative at GlaxoSmithKline in October 1998, where they worked until May 2005.
Basel Ziyadeh holds an Executive MBA in Business Administration and Management, General from the American University of Beirut. Basel also obtained a BSc in Biological Sciences from the University of Jordan.
Julphar
2 followers
The Julphar story is one of innovation and leadership. Since our journey began in 1980, our goal has remained the same – to bring better healthcare and a brighter future to families across the globe. And in less than 40 years, we have expanded our network across the Middle East and Africa to become one of the largest pharmaceutical manufacturers in the region. Headquartered in Ras Al Khaimah in the United Arab Emirates, we employ 2,500 people worldwide, and we market our products in more than 50 countries. We have 13 internationally accredited facilities that produce more than half a million medicine boxes a day, including tablets, syrups, suspensions, creams and injectables, and vaccines. Julphar has an extensive portfolio of generic medicines, branded generics, and over-the-counter medicines, as well as APIs (active pharmaceutical ingredients). We develop and manufacture medicines and supplements for everything from the common cold to diabetes.